STEREOTAXIS, INC.
ST LOUIS, MO

Stereotaxis, Inc. is a company headquartered in St. Louis, MO, dedicated to advancing the field of electrophysiology and arrhythmia treatment through cutting-edge technology. Known for its magnetic navigation system, Stereotaxis enables physicians worldwide to perform complex cardiac interventions with enhanced precision, safety, and effectiveness. Since 2004, this pioneering technology has facilitated thousands of procedures in over 30 countries by offering remote navigation that simplifies reaching otherwise inaccessible regions of the heart. With an impeccable safety record—99.9% complication-free procedure completion rate at a global scale—Stereotaxis also significantly reduces x-ray exposure for both physicians and patients. Committed to innovation, Stereotaxis collaborates with major medical device manufacturers like Siemens and Philips while integrating its technology into existing cath lab imaging systems. The company’s comprehensive training programs equip healthcare providers to maximize their use of Stereotaxis systems, often leading to new technological developments. Endorsed by world-leading cardiac specialists, the system is acclaimed for enabling efficient procedures without physical toll on practitioners. Founded in September 2009 as a Registered Foreign Corporation (FORP) with a filing number F09000003788, Steroetaxis has its mailing address at 710 N Tucker Blvd, Suite 110, in St. Louis, MO. Current leadership includes Director David Benfer, CEO David L. Fischel, and Director Robert J. Messey, with the company holding FEI number 943120386. The organization was most recently involved in a REINSTATEMENT event on September 28, 2023, and filed its annual report for the year 2024 dated April 3, 2024. For further information, Stereotaxis can be contacted via their website at stererotaxis.com or through phone numbers (866) 646-2346; (314) 678-6100; and (314) 678-6159.